Biotech firm ConservoCare obtains licensing options from Case Western Reserve University (CWRU).

CWRU has given the green light to its spin-off, biotech firm ConservoCare, to obtain licensing options to develop a medical device for bladder control.

The Atlanta-based firm focuses on restoring bladder function lost through injury or illness. ConservoCare’s device, developed at CWRU, can allow the user to control their bladder through electrical nerve stimulation.

Funded CWRU’s Translational Research Partnership and by $125k from the National Institutes of Health’s Small Business Technology Transfer program, the company is in the process of…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?